Browse Category

Investment Analysis News 12 December 2025

Merck (MRK) Stock News Today: Winrevair EU Expansion, Keytruda Patent Headwinds, Analyst Forecasts and What Investors Watch (Dec. 12, 2025)

Merck (MRK) Stock News Today: Winrevair EU Expansion, Keytruda Patent Headwinds, Analyst Forecasts and What Investors Watch (Dec. 12, 2025)

Merck & Co., Inc. (NYSE: MRK) stock traded higher on Friday, December 12, 2025, as investors weighed a new European regulatory tailwind for pulmonary arterial hypertension drug WINREVAIR (sotatercept) against a backdrop of policy-driven vaccine headlines, Keytruda-related legal friction in
First Majestic Silver (AG) Stock News Today (Dec. 12, 2025): Silver’s Record Run Fuels Volatility, Convertible Notes Refinancing, and Fresh Analyst Targets

First Majestic Silver (AG) Stock News Today (Dec. 12, 2025): Silver’s Record Run Fuels Volatility, Convertible Notes Refinancing, and Fresh Analyst Targets

First Majestic Silver Corp. (NYSE: AG , TSX: AG ) is ending the week in the center of one of the most explosive precious-metals backdrops in years. On Friday, December 12, 2025 , AG shares swung sharply—trading around $15.77 after
Altimmune (ALT) Stock News, Forecasts and Analysis for Dec. 12, 2025: What Investors Are Watching Ahead of Pemvidutide Catalysts

Altimmune (ALT) Stock News, Forecasts and Analysis for Dec. 12, 2025: What Investors Are Watching Ahead of Pemvidutide Catalysts

Altimmune, Inc. (NASDAQ: ALT) is back on many biotech watchlists as investors weigh two competing forces: a near-term clinical and regulatory catalyst calendar for pemvidutide (the company’s lead asset) and a capital-raising backdrop that can quickly change the stock’s risk/reward
Lumentum (LITE) Stock Slides on AI-Tech Selloff as Analysts Lift Price Targets to $380 — What Today’s News and Forecasts Say (Dec. 12, 2025)

Lumentum (LITE) Stock Slides on AI-Tech Selloff as Analysts Lift Price Targets to $380 — What Today’s News and Forecasts Say (Dec. 12, 2025)

Dec. 12, 2025 — Lumentum Holdings Inc. (NASDAQ: LITE) is back in focus today as the stock pulls back sharply after a powerful AI-driven run. During Friday’s U.S. session, Lumentum shares traded around $332 (midday update), down roughly 10% from
Warner Bros. Discovery Stock (WBD) Today: Netflix Deal vs. Paramount’s $30 Tender Offer, Latest News, Analyst Forecasts and What Comes Next (Dec. 12, 2025)

Warner Bros. Discovery Stock (WBD) Today: Netflix Deal vs. Paramount’s $30 Tender Offer, Latest News, Analyst Forecasts and What Comes Next (Dec. 12, 2025)

Warner Bros. Discovery, Inc. Series A shares (Nasdaq: WBD) are trading around the high-$20s on December 12, 2025, after a week that has turned the company into the center of a rare, high-stakes takeover fight—one that could reshape streaming, Hollywood’s
Broadcom Stock Slides After Q4 Earnings: AI Chip Revenue Set to Double, but Margin Pressure Rattles Investors

Broadcom Stock Slides After Q4 Earnings: AI Chip Revenue Set to Double, but Margin Pressure Rattles Investors

December 12, 2025 — Broadcom’s latest earnings were strong on the surface: record quarterly revenue, a beat on profit, and guidance that topped Wall Street expectations. Yet the market reaction on Friday was unmistakably cautious. Broadcom (NASDAQ: AVGO) sank sharply
AST SpaceMobile (ASTS) Stock on Dec. 12, 2025: BlueBird 6 Launch Date Shifts, Analyst Forecasts Diverge, and the Direct-to-Device Race Intensifies

AST SpaceMobile (ASTS) Stock on Dec. 12, 2025: BlueBird 6 Launch Date Shifts, Analyst Forecasts Diverge, and the Direct-to-Device Race Intensifies

December 12, 2025 — AST SpaceMobile, Inc. (NASDAQ: ASTS) is back in the spotlight as investors weigh a pivotal near-term catalyst (the first “next-generation” BlueBird satellite launch) against the realities of execution risk, schedule slips, and a valuation debate that
1 49 50 51 52 53 156
Go toTop